SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 20 of 100
Newsletters
A powerhouse trio pledges up to $125 million to fight coronavirus
By
Sy Mukherjee
Health
Gates Foundation, Mastercard, and Wellcome team up to fuel coronavirus drug development
By
Sy Mukherjee
Newsletters
Beware the coronavirus snake oil salesmen
By
Sy Mukherjee
Newsletters
CVS will waive out-of-pocket costs related to coronavirus testing and telemedicine visits
By
Sy Mukherjee
Health
What the rising coronavirus death rate really means
By
Sy Mukherjee
Newsletters
CRISPR has a milestone moment in treating blindness
By
Sy Mukherjee
Newsletters
The coronavirus testing conundrum
By
Sy Mukherjee
Health
Testing for coronavirus should be free, but it’s not always that simple
By
Sy Mukherjee
Newsletters
Amazon’s Alexa can now give you detailed information on your medications
By
Sy Mukherjee
Newsletters
Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response
By
Sy Mukherjee
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By
Sy Mukherjee
Newsletters
Can Gilead tame the coronavirus?
By
Sy Mukherjee
Health
Gilead’s coronavirus treatment is barreling its way into new clinical trials
By
Sy Mukherjee
Newsletters
Apple and Johnson & Johnson team up on heart study
By
Sy Mukherjee
Health
The first U.S. trial for a coronavirus treatment has started
By
Sy Mukherjee